Phase 2 study of AV-GBM-1 (a tumor-initiating cell targeted dendritic cell vaccine) in newly diagnosed Glioblastoma patients: safety and efficacy assessment
Bota, Daniela A, Taylor, Thomas H, Piccioni, David E, Duma, Christopher M, LaRocca, Renato V, Kesari, Santosh, Carrillo, Jose A, Abedi, Mehrdad, Aiken, Robert D, Hsu, Frank P K, Kong, Xiao-Tang, Hsieh, Candace, Bota, Peter G, Nistor, Gabriel I, Keirstead, Hans S, Dillman, Robert O
Published in Journal of experimental & clinical cancer research (14.12.2022)
Published in Journal of experimental & clinical cancer research (14.12.2022)
Get full text
Journal Article
Phase II Study of Belagenpumatucel-L, a Transforming Growth Factor Beta-2 Antisense Gene-Modified Allogeneic Tumor Cell Vaccine in Non–Small-Cell Lung Cancer
NEMUNAITIS, John, DILLMAN, Robert O, DEVOL, Edward, MAPLES, Phillip B, LIU, Lily, CHAMBERLIN, Terry, SHAWLER, Daniel L, FAKHRAI, Habib, SCHWARZENBERGER, Paul O, SENZER, Neil, CUNNINGHAM, Casey, CUTLER, Jodi, TONG, Alex, KUMAR, Padmasini, PAPPEN, Beena, HAMILTON, Cody
Published in Journal of clinical oncology (10.10.2006)
Published in Journal of clinical oncology (10.10.2006)
Get full text
Journal Article
Randomized phase II trial of autologous dendritic cell vaccines versus autologous tumor cell vaccines in metastatic melanoma: 5-year follow up and additional analyses
Dillman, Robert O, Cornforth, Andrew N, Nistor, Gabriel I, McClay, Edward F, Amatruda, Thomas T, Depriest, Carol
Published in Journal for immunotherapy of cancer (06.03.2018)
Published in Journal for immunotherapy of cancer (06.03.2018)
Get full text
Journal Article
Genomic, proteomic, and immunologic associations with a durable complete remission of measurable metastatic melanoma induced by a patient-specific dendritic cell vaccine
Dillman, Robert O., Nistor, Gabriel I., Poole, Aleksandra J.
Published in Human vaccines & immunotherapeutics (02.04.2020)
Published in Human vaccines & immunotherapeutics (02.04.2020)
Get full text
Journal Article
A personal COVID-19 dendritic cell vaccine made at point-of-care: Feasibility, safety, and antigen-specific cellular immune responses
Nistor, Gabriel I., Dillman, Robert O., Robles, Rockelle M., Langford, James L., Poole, Aleksandra J., Sofro, Muchlis A. U., Nency, Yetty M., Jonny, Jonny, Yana, Martina L., Karyana, Mahammad, Lestari, Endang S., Triwardhani, Ria, Mujahidah, Mujahidah, Sari, Retty K., Soetojo, Nur A., Wibisono, Djoko, Tjen, Daniel, Ikrar, Taruna, Sarkissian, Gregory, Winarta, Haryono, Putranto, Terawan A., Keirstead, Hans S.
Published in Human vaccines & immunotherapeutics (30.11.2022)
Published in Human vaccines & immunotherapeutics (30.11.2022)
Get full text
Journal Article
Overall Survival Benefit From Postoperative Radiation Therapy for Organ-Confined, Margin-Positive Prostate Cancer
Dillman, Robert O., M.D, Hafer, Russell, M.D, Cox, Craig, M.D, McClure, Stephanie E., C.T.R
Published in International journal of radiation oncology, biology, physics (01.03.2011)
Published in International journal of radiation oncology, biology, physics (01.03.2011)
Get full text
Journal Article
Intracavitary placement of autologous lymphokine-activated killer (LAK) cells after resection of recurrent glioblastoma
Dillman, Robert O, Duma, Christopher M, Schiltz, Patric M, DePriest, Carol, Ellis, Robin A, Okamoto, Kris, Beutel, Linda D, De Leon, Cristina, Chico, Sherri
Published in Journal of immunotherapy (1997) (01.09.2004)
Published in Journal of immunotherapy (1997) (01.09.2004)
Get more information
Journal Article